Neutrophil recovery characteristics in patients with severe antithyroid drug-induced agranulocytosis: A 12-year retrospective study
- 28 September 2026
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 91 (1) , 315
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation for Young Scientists of Shanxi Province (82300882)
- the General project, Shaanxi Science and Technology Research (2022SF-103)
This publication has 29 references indexed in Scilit:
- Antithyroid drug-induced leukopenia and G-CSF administration: a long-term cohort studyScientific Reports, 2023
- MICA polymorphisms associated with antithyroid drug‐induced agranulocytosis in the Chinese Han populationImmunity, Inflammation and Disease, 2020
- HLA-B*39:01:01 is a novel risk factor for antithyroid drug-induced agranulocytosis in Japanese populationThe Pharmacogenomics Journal, 2020
- Global epidemiology of hyperthyroidism and hypothyroidismNature Reviews Endocrinology, 2018
- Emphasis on the early diagnosis of antithyroid drug-induced agranulocytosis: retrospective analysis over 16 years at one Chinese centerJournal of Endocrinological Investigation, 2017
- Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and ManagementDrugs in R&D, 2017
- Agranulocytoses aux antithyroïdiens de synthèse : revue de la littératureLa Revue de Médecine Interne, 2016
- Leukemoid reaction–A tale of 50 yearsIndian Pediatrics, 2015
- Idiosyncratic drug-induced agranulocytosis: Update of an old disorderEuropean Journal of Internal Medicine, 2006
- Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopeniaArchives of internal medicine (1960), 1993